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INTRODUCTION
SCREENING women for the detection of breast cancer by examination is well
established although not yet fully assessed. Studies, like that of the HIP1 in New
York, have shown that screening, including mammography, has probably little
value under the age of 50 and this is supported by other studies. Nevertheless,
publicity has increasingly induced younger women to seek what they believe to be
the benefits of clinical screening, and screening for breast lesions is carried out
routinely in many family planning and well women clinics where young women
predominate. Screening programmes developed by charitable and commercial
organisations also extend screening facilities to all ages of women.
This study was undertaken to evaluate breast screening byexamination in women
under the age of 30 and to relate this to the incidence of breast biopsy in hospital
practice.
METHODS
In the first study the records ofall women who had been operated on inthe Royal
Victoria Hospital from 1970-1979 were assessed. Only women who had a formal
excisional biopsyofthebreast lump wereincluded. Information wasobtained onthe
annual numbers operated on, age at first presentation, the diagnosis and the time
which elapsed between first noticing the lump and presentation.
In the second part of the study information was collected on women seen at
screening clinics organised by 'Action Cancer' in Ulster. Patients were examined by
a doctor in the main clinic or were seen in a mobile unit by a nurse who would refer
some patients to the doctor at the centre. During thetime under study most patients
were seen by one particular doctor and one nurse. Mammography was not used in
women under 40.
Theresults cover aperiod from September 1978 whenthecentreopened totheend
ofApril 1980.
RESULTS
In the-first-study 297 patients qualified for inclusion in the study and of these 28
charts were unobtainable leaving 269 patients as the study population. In 1970 28
excisional biopsies were carried out and these fell to 16 in 1972 but since then have
steadily risen until in 1979 44 were performed (Figure 1). The fall in 1972 was
probably associated with difficulty of access to the Hospital during periods ofcivil
disturbance.
The diagnosis was determined from the histological reports (Table 1). There were
106 patients (40 per cent) with thediagnosis offibro-adenoma andtheir distribution
throughout the 10 years does not show the same rising incidence (Figure 1).
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On the assumption that the number of fibro-adenomas biopsied does not vary
significantly from year to year, this number can be used as an indicator of whether
the population presenting with breast lumps is changing. With the exception of 1979
there is a noticeable and significant increase in the number ofbiopsies for conditions
other than fibroadenoma. There were only three cases of carcinoma detected. Most
of the remaining cases were diagnosed as showing various forms of fibro-cystic
disease. Almost 70 per cent of the patients presented for treatment within three
months of first noticing an abnormality.
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10In the second study there were 5926 patients who had been seen at screening
clinics. 1329 ofthese were under 30 and these formed the study population. Ofthese
women under 30, 92 (7.0 per cent) were noted to have abnormalities, only 8 (0.6 per
cent) were referred to hospital and biopsy was undertaken in only 4 ofthem (0.3 per
cent) (Table 2). Almost a quarter, therefore, of the patients attending the screening
clinics were under 30 years of age and this is the result of the mobile unit visiting
areas where there are businesses and offices employing many younger women.
TABLE 1 TABLE 2
Table ofPathologicalDiagnosis Screening Clinic Results
Diagnosis No.
Fibro-adenoma 106
Fibro-adenosis 85
Fibro-cystic disease 21
Combinations ofabove 26
Miscellaneous 28
Carcinoma 3
Total patients seen 5926
Total women under 30 1329
Total with abnormalities 92
Hospital referrals 8
Biopsy undertaken 4
The records of the 92 women in whom an abnormality was detected were
examined. The abnormality noted ranged from a diffuse thickening to a definite
lump. Most ofthem werereviewed before being referred to ahospital clinic, with the
consequence that only 8 with a discrete persistent mass were eventually sent for a
further opinion. Amongst those that were not referred were 22 who had previously
proven breast disease, ranging from infections to benign lumps operatively
removed. Of those referred to hospital only half (4) had biopsies and all of these
were benign.
At the end of each patient's visit to these clinics, the patients were taught self-
examination of their breast and encouraged to continue doing so.
DISCUSSION
Breast cancer is very unusual in women under 30. The Registrar-General's reports
for England and Wales2 show an annual death rate from breast cancer which
averages 11,000 and of these only about 30 are under the age of 30. Equivalent
figures in Northern Ireland show that no woman under 30 died in the years 1970-77
from breast cancer and this study revealed only 3 cases in the decade 1970-79 in this
hospital. All these are alive at present. Nevertheless an increasing number of young
women are having excisional biopsies of benign breast lumps. However, it must be
assumed that the pattern of breast disease in young women is unlikely to have
altered between 1970-1979 andthis suggests thattheindications for breastbiopsy are
changing and becoming much wider. The only lumps-that need to be removed are
the fibro-adenomas and carcinomas and these do not seen to have changed in
hospital incidence. It is clear therefore that the increasing number ofbreast biopsies
are carried out for diffuse disease which is likely to regress spontaneously.
It is difficult to ignore a breast lump once it has been noticed so the progression
from detection to excision may become inevitable. No other diagnostic technique
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carcinoma. However, the clinical signs of fibro-adenoma and carcinoma do differ
very significantly from those of the cyclical changes in the breast of young women
and avoidance ofunnecessary surgical excision is also a desirable aim. These young
women attend for reassurance and there are probably many patients for whom
authorative reassurance would avoid the necessity for breast biopsy and in whom a
period ofobservation would confirm the disappearance ofthe abnormality.
In the last few years there has been much publicity, both in the commercial press
and in various agencies for health education, to encourage women to attend
screening clinics and to examine their own breasts regularly. Often no distinction is
made between young and old women or if it is made it is not emphasised. The
consequence is thatmanyyoung women, often intheir teens. feeltheymust examine
their breasts regularly and become apprehensive about the prospects of developing
malignant disease ofthe breast,
Benefits to young women ofscreening clinics for breast cancer must be looked at
critically. Published results of screening have usually had a lower cut off age of
40-45 years as the low risk in young women is well recognised and the results ofthe
HIP' study fail to show benefits of screening in young women. In 1976 the
Edi-nburgh Family Planniing Clinic3 reported on routine breast examination in
young women concluding that it had no merit and that such examination should be
restricted to women over 40 years.
Several conclusions can be drawn from this paper. Firstly, the increasing number
of breast biopsies being performed on young women in this hospital is related to
biopsies for benign, diffuse disease and a more critical attitude could reduce this
number ofbiopsies without anyrisk to patients. Secondly, there is no great delay in
women presenting for a medical opinion when they do notice an abnormality in the
breast. Thirdly, there is no benefit from screening young women nor in suggesting
that they should carry out regular breast self examination. Anxiety generated by
such a policy is not compensated for by any therapeutic advantage.
As a result of this study Action Cancer have decided that they will no longer
screen breasts of women under 30 years except in the case of a specific complaint.
Family planning clinics and well woman screening clinics should also cease to
examine the breasts ofwomen under the age of 30.
SUMMARY
The number of breast biopsies performed on women under 30 years of age has
been increasing in this hospital in recent years. A survey of a local cancer screening
clinicinvolving 5926patients, revealedthat 1329 were under 30yearsofageandonly
8 of these were subsequently referred for a surgical opinion. Only 4 ofthese had a
formal biopsy. The clinic has altered its policy and abandoned routine examination
ofbreasts in under thirties. It is suggested that this policy should bewidelyaccepted
to allay anxiety in young women.
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